(Q37508032)

20 August 2017

1 reference

title

Definition and management of patients with bladder cancer who fail BCG therapy (English)

1 reference

20 August 2017

1 reference

Frances M Martin

1

1 reference

20 August 2017

Ashish M Kamat

series ordinal

2

1 reference

20 August 2017

publication date

1 June 2009

1 reference

Expert Review of Anticancer Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

9

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

815-820

1 reference

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

20 August 2017

cites work

1 reference

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials

21 January 2018

1 reference

Treatment options for BCG failures.

21 January 2018

1 reference

Preventing progression and improving survival with BCG maintenance

21 January 2018

1 reference

Additional bacillus Calmette-Guérin therapy for recurrent transitional cell carcinoma after an initial complete response

21 January 2018

1 reference

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

21 January 2018

1 reference

Beware the BCG failures: a review of one institution's results

21 January 2018

1 reference

Controversial issues and optimal management of stage T1G3 bladder cancer

21 January 2018

1 reference

Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study.

21 January 2018

1 reference

Intravesicle gemcitabine in management of BCG refractory superficial TCC of urinary bladder-our experience

21 January 2018

1 reference

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

21 January 2018

1 reference

Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer

21 January 2018

1 reference

Response of multiple recurrent TaT1 bladder cancer to intravesical apaziquone (EO9): comparative analysis of tumor recurrence rates.

21 January 2018

1 reference

Oral bropirimine immunotherapy of bladder carcinoma in situ after prior intravesical bacille Calmette-Guérin.

21 January 2018

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

21 January 2018

1 reference

BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.09.35

1 reference

20 August 2017

1 reference